Acute Myeloblastic Leukemia and Myelodysplastic Syndrome: Azacitidine for Prophylactic and Preventive Purposes after Allogeneic Hematopoietic Stem Cell Transplantation
Aim. To evaluate the effectiveness of preventive and prophylactic post-transplantation therapy using azacitidine (5-AZA) in patients at high risk of post-transplantation relapse. Methods. 136 patients were included in the study performed by the pairwise comparison: 68 of them received 5-AZA after...
Main Authors: | VN Ovechkina, SN Bondarenko, EV Morozova, IS Moiseev, OA Slesarchuk, AG Smirnova, OS Uspenskaya, YaV Gudozhnikova, AA Osipova, VS Sergeev, NN Mamaev, LS Zubarovskaya, BV Afanas’ev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Practical Medicine Publishing House
2017-01-01
|
Series: | Kliničeskaâ onkogematologiâ |
Subjects: | |
Online Access: | http://bloodjournal.ru/wp-content/uploads/2017/01/6.pdf |
Similar Items
-
The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
by: VN Ovechkina, et al.
Published: (2017-07-01) -
Myelodysplastic syndromes: therapeutic problems and decisions (review)
by: S. V. Semochkin, et al.
Published: (2014-07-01) -
Myelodysplastic syndromes: therapeutic problems and decisions (review)
by: S. V. Semochkin, et al.
Published: (2014-07-01) -
Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
by: Guangjie Zhao, et al.
Published: (2021-09-01) -
Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome
by: Ritchie EK
Published: (2012-06-01)